share_log

Merit Medical Launches the TEMNO Elite Soft Tissue Biopsy System

Benzinga Real-time News ·  Sep 27, 2022 09:26

Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the TEMNO Elite Soft Tissue Biopsy System, the latest addition to Merit's comprehensive portfolio of biopsy devices.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment